RedHill On The Rise With Three Drugs And Potential COVID-19 Therapy
Strong Commercial Arm in US
The Israeli biotech which is listed on the NASDAQ is in for a busy 2021 with strong marketing pushes for Movantik, Aemcolo and Talicia and completing a pivotal trial for COVID-19 hopeful opaganib.
